Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?
about
Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusSafety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Saxagliptin for the treatment of diabetes - a focus on safety.Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.RETRACTED: Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment.
P2860
Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Are incretin mimetics and enha ...... t transformations in pancreas?
@en
type
label
Are incretin mimetics and enha ...... t transformations in pancreas?
@en
prefLabel
Are incretin mimetics and enha ...... t transformations in pancreas?
@en
P2860
P1476
Are incretin mimetics and enha ...... t transformations in pancreas?
@en
P2093
Burkhard Göke
Jocelyn de Heer
P2860
P304
P356
10.1517/14740338.2014.955013
P407
P577
2014-10-01T00:00:00Z